Joint Formulary & PAD

Montelukast - Urticaria

You are here : Home > Formulary Search > Montelukast - Urticaria

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Chewable tablets
  • Sachets (granules)
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Montelukast
Indication :
Urticaria
Group Name :
Keywords :
chronic idiopathic urticaria, pruritis, itching
Brand Names Include :
Important Information :

Off-label use.

For use if there is an inadequate response to increased dose antihistamine treatment.

https://www.gov.uk/drug-safety-update/montelukast-singulair-reminder-of-the-risk-of-neuropsychiatric-reactions

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Montelukast is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Urticaria.